COHERUS BIOSCIENCES INC's ticker is CHRS and the CUSIP is 19249H103. A total of 186 filers reported holding COHERUS BIOSCIENCES INC in Q1 2020. The put-call ratio across all filers is 1.03 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $1,253,000 | +12.3% | 293,538 | +79.9% | 0.17% | +6.9% |
| Q1 2023 | $1,116,000 | -51.3% | 163,140 | -48.4% | 0.16% | -53.4% |
| Q2 2022 | $2,291,000 | -53.8% | 316,455 | -17.6% | 0.34% | -44.4% |
| Q1 2022 | $4,958,000 | -39.6% | 384,010 | -25.4% | 0.62% | -41.0% |
| Q4 2021 | $8,210,000 | +1.2% | 514,438 | +1.9% | 1.04% | +1.9% |
| Q3 2021 | $8,114,000 | +133.4% | 504,936 | +100.9% | 1.03% | +134.2% |
| Q2 2021 | $3,476,000 | +18.0% | 251,358 | +24.7% | 0.44% | +12.9% |
| Q1 2021 | $2,946,000 | +65.2% | 201,628 | +96.5% | 0.39% | +42.1% |
| Q4 2020 | $1,783,000 | -21.2% | 102,615 | -16.9% | 0.27% | -29.8% |
| Q3 2020 | $2,264,000 | +6.1% | 123,462 | +3.3% | 0.39% | +2.6% |
| Q2 2020 | $2,134,000 | +1.3% | 119,516 | -8.0% | 0.38% | -10.6% |
| Q1 2020 | $2,106,000 | +3.0% | 129,859 | +14.4% | 0.42% | +72.4% |
| Q4 2019 | $2,044,000 | – | 113,548 | – | 0.25% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANG CAPITAL MANAGEMENT LLC | 650,000 | $10,374,000 | 2.09% |
| CM Management, LLC | 125,000 | $1,995,000 | 1.51% |
| Perceptive Advisors | 10,815,596 | $172,616,000 | 1.33% |
| Bridge City Capital, LLC | 163,198 | $2,605,000 | 1.07% |
| Phocas Financial Corp. | 514,438 | $8,210,000 | 1.04% |
| Redwood Investments, LLC | 709,184 | $11,319,000 | 0.89% |
| Aristotle Capital Boston, LLC | 2,087,187 | $33,312,000 | 0.78% |
| Knott David M Jr | 102,555 | $1,637,000 | 0.56% |
| Zebra Capital Management LLC | 16,746 | $267,000 | 0.43% |
| Temasek Holdings (Private) Ltd | 7,381,116 | $117,803,000 | 0.42% |